Loading…

Inhibition of endotoxin-induced TNF-α production in macrophages by 5Z-7- oxo-zeaenol and other fungal resorcylic acid lactones

Resorcylic acid lactones are fungal metabolites that exhibit a wide range of biological properties which includes oestrogenic, antifungal, phytotoxic and anti-inflammatory activity. The capacity of 5Z-7- oxo-zeaenol, a resorcylic lactone of fungal origin and six naturally occurring analogues to inhi...

Full description

Saved in:
Bibliographic Details
Published in:International journal of immunopharmacology 1999-12, Vol.21 (12), p.799-814
Main Authors: Rawlins, Philip, Mander, Thomas, Sadeghi, Roya, Hill, Simon, Gammon, Guy, Foxwell, Brian, Wrigley, Stephen, Moore, Michael
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c421t-e129577161a667a2414ea4a69ce7b3c5db0c21ed25d88863f73df085139b02663
cites cdi_FETCH-LOGICAL-c421t-e129577161a667a2414ea4a69ce7b3c5db0c21ed25d88863f73df085139b02663
container_end_page 814
container_issue 12
container_start_page 799
container_title International journal of immunopharmacology
container_volume 21
creator Rawlins, Philip
Mander, Thomas
Sadeghi, Roya
Hill, Simon
Gammon, Guy
Foxwell, Brian
Wrigley, Stephen
Moore, Michael
description Resorcylic acid lactones are fungal metabolites that exhibit a wide range of biological properties which includes oestrogenic, antifungal, phytotoxic and anti-inflammatory activity. The capacity of 5Z-7- oxo-zeaenol, a resorcylic lactone of fungal origin and six naturally occurring analogues to inhibit lipopolysaccharide (LPS)-induced cytokine production in phorbol 12-myristate-13-acetate (PMA)-treated cultured myelomonocytic cells (U937) was compared. The activity of the natural analogues in the U937 assay varied over 10 4-fold, with 5Z-7- oxo-zeaenol the most potent of those tested inhibiting tumour necrosis factor-alpha (TNFα) production in these cells with IC 50 of 6 nM. The isomeric 7- oxo-zeaenol and structurally more distant monorden (radicicol) were the next most active compounds with IC 50 ∼500 nM, and zearalenone, the least active with IC 50>400 μM. 5Z-7- oxo-zeaenol retained activity in LPS-stimulated peripheral blood mononuclear cells with an IC 50 of 10–25 nM. This compound also inhibited LPS-induced TNFα production in whole blood experiments (IC 50 100–1000 nM) and lowered serum levels of TNFα in mice when administered prior to LPS. 5Z-7- oxo-zeaenol was shown to inhibit the phosphorylation and activation of mitogen-activated protein kinase (MAPK) induced by LPS. These data are consistent with a mechanism of action at or upstream of MAPK with resultant downstream effects. This series of naturally occurring analogues represents an interesting group of compounds with diverse biological properties. Of this series, 5Z-7- oxo-zeanenol has exceptionally potent anti-inflammatory properties exhibited by its strong inhibition of cytokine production.
doi_str_mv 10.1016/S0192-0561(99)00047-8
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17434546</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0192056199000478</els_id><sourcerecordid>17434546</sourcerecordid><originalsourceid>FETCH-LOGICAL-c421t-e129577161a667a2414ea4a69ce7b3c5db0c21ed25d88863f73df085139b02663</originalsourceid><addsrcrecordid>eNqFkbtuFDEUQC1ERJbAJ4BcIASFwZ7xY1xFKCIQKQoFoaGxPPadrNGsvdgzKEvDN_Ej-Sa8DwU65OLK0rmvcxF6xugbRpl8-5ky3RAqJHul9WtKKVeke4AWrFOatFyLh2hxjxyjx6V8q5BgsnmEjhmV9VG2QL8u4jL0YQop4jRgiD5N6TZEEqKfHXh8fXVO7n7jdU71v8NCxCvrclov7Q0U3G-w-EoUwek2kZ9gIaYR2-hxmpaQ8TDHGzviDCVltxmDw9YFj0frphShPEFHgx0LPD3EE_Tl_P312Udy-enDxdm7S-J4wyYCrNFCKSaZlVLZhjMOllupHai-dcL31DUMfCN813WyHVTrB9oJ1uqeNlK2J-jlvm5d5PsMZTKrUByMo42Q5mKY4i0XfAuKPVg3LCXDYNY5rGzeGEbN1rzZmTdbrUZrszNvupr3_NBg7lfg_8naq67AiwNgi7PjkG10ofzl6uFEt-1_useg2vgRIJviAsR6ipDBTcan8J9J_gDPAqCE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17434546</pqid></control><display><type>article</type><title>Inhibition of endotoxin-induced TNF-α production in macrophages by 5Z-7- oxo-zeaenol and other fungal resorcylic acid lactones</title><source>ScienceDirect Freedom Collection</source><creator>Rawlins, Philip ; Mander, Thomas ; Sadeghi, Roya ; Hill, Simon ; Gammon, Guy ; Foxwell, Brian ; Wrigley, Stephen ; Moore, Michael</creator><creatorcontrib>Rawlins, Philip ; Mander, Thomas ; Sadeghi, Roya ; Hill, Simon ; Gammon, Guy ; Foxwell, Brian ; Wrigley, Stephen ; Moore, Michael</creatorcontrib><description>Resorcylic acid lactones are fungal metabolites that exhibit a wide range of biological properties which includes oestrogenic, antifungal, phytotoxic and anti-inflammatory activity. The capacity of 5Z-7- oxo-zeaenol, a resorcylic lactone of fungal origin and six naturally occurring analogues to inhibit lipopolysaccharide (LPS)-induced cytokine production in phorbol 12-myristate-13-acetate (PMA)-treated cultured myelomonocytic cells (U937) was compared. The activity of the natural analogues in the U937 assay varied over 10 4-fold, with 5Z-7- oxo-zeaenol the most potent of those tested inhibiting tumour necrosis factor-alpha (TNFα) production in these cells with IC 50 of 6 nM. The isomeric 7- oxo-zeaenol and structurally more distant monorden (radicicol) were the next most active compounds with IC 50 ∼500 nM, and zearalenone, the least active with IC 50&gt;400 μM. 5Z-7- oxo-zeaenol retained activity in LPS-stimulated peripheral blood mononuclear cells with an IC 50 of 10–25 nM. This compound also inhibited LPS-induced TNFα production in whole blood experiments (IC 50 100–1000 nM) and lowered serum levels of TNFα in mice when administered prior to LPS. 5Z-7- oxo-zeaenol was shown to inhibit the phosphorylation and activation of mitogen-activated protein kinase (MAPK) induced by LPS. These data are consistent with a mechanism of action at or upstream of MAPK with resultant downstream effects. This series of naturally occurring analogues represents an interesting group of compounds with diverse biological properties. Of this series, 5Z-7- oxo-zeanenol has exceptionally potent anti-inflammatory properties exhibited by its strong inhibition of cytokine production.</description><identifier>ISSN: 0192-0561</identifier><identifier>EISSN: 1879-3495</identifier><identifier>DOI: 10.1016/S0192-0561(99)00047-8</identifier><identifier>PMID: 10606001</identifier><identifier>CODEN: IJIMDS</identifier><language>eng</language><publisher>Oxford: Elsevier Science</publisher><subject>5Z-7- oxo-zeaenol ; 5Z-7-^Aoxo-zeaenol ; Adult ; Animals ; Anti-Inflammatory Agents, Non-Steroidal - pharmacology ; Ascomycota - chemistry ; Biological and medical sciences ; Bones, joints and connective tissue. Antiinflammatory agents ; Humans ; Hydroxybenzoates - pharmacology ; L Cells (Cell Line) - drug effects ; Lactones - pharmacology ; Lipopolysaccharide ; lipopolysaccharides ; Lipopolysaccharides - antagonists &amp; inhibitors ; Lipopolysaccharides - pharmacology ; Macrolides ; Macrophages - drug effects ; MAP Kinase Signaling System - drug effects ; Medical sciences ; Mice ; Mice, Inbred BALB C ; Mitogen-activated protein kinase ; Molecular Structure ; Monocytes ; Pharmacology. Drug treatments ; Receptors, Estrogen - metabolism ; Receptors, Glucocorticoid - metabolism ; Recombinant Fusion Proteins - pharmacology ; Resorcylic acid lactones ; Signal transduction ; Structure-Activity Relationship ; Tetradecanoylphorbol Acetate - pharmacology ; tumor necrosis factor-^a ; Tumor Necrosis Factor-alpha - biosynthesis ; Tumour necrosis factor-alpha ; U937 Cells - drug effects ; Zearalenone - analogs &amp; derivatives ; Zearalenone - chemistry ; Zearalenone - isolation &amp; purification ; Zearalenone - pharmacology</subject><ispartof>International journal of immunopharmacology, 1999-12, Vol.21 (12), p.799-814</ispartof><rights>1999 International Society for Immunopharmacology</rights><rights>2000 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c421t-e129577161a667a2414ea4a69ce7b3c5db0c21ed25d88863f73df085139b02663</citedby><cites>FETCH-LOGICAL-c421t-e129577161a667a2414ea4a69ce7b3c5db0c21ed25d88863f73df085139b02663</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1187586$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10606001$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rawlins, Philip</creatorcontrib><creatorcontrib>Mander, Thomas</creatorcontrib><creatorcontrib>Sadeghi, Roya</creatorcontrib><creatorcontrib>Hill, Simon</creatorcontrib><creatorcontrib>Gammon, Guy</creatorcontrib><creatorcontrib>Foxwell, Brian</creatorcontrib><creatorcontrib>Wrigley, Stephen</creatorcontrib><creatorcontrib>Moore, Michael</creatorcontrib><title>Inhibition of endotoxin-induced TNF-α production in macrophages by 5Z-7- oxo-zeaenol and other fungal resorcylic acid lactones</title><title>International journal of immunopharmacology</title><addtitle>Int J Immunopharmacol</addtitle><description>Resorcylic acid lactones are fungal metabolites that exhibit a wide range of biological properties which includes oestrogenic, antifungal, phytotoxic and anti-inflammatory activity. The capacity of 5Z-7- oxo-zeaenol, a resorcylic lactone of fungal origin and six naturally occurring analogues to inhibit lipopolysaccharide (LPS)-induced cytokine production in phorbol 12-myristate-13-acetate (PMA)-treated cultured myelomonocytic cells (U937) was compared. The activity of the natural analogues in the U937 assay varied over 10 4-fold, with 5Z-7- oxo-zeaenol the most potent of those tested inhibiting tumour necrosis factor-alpha (TNFα) production in these cells with IC 50 of 6 nM. The isomeric 7- oxo-zeaenol and structurally more distant monorden (radicicol) were the next most active compounds with IC 50 ∼500 nM, and zearalenone, the least active with IC 50&gt;400 μM. 5Z-7- oxo-zeaenol retained activity in LPS-stimulated peripheral blood mononuclear cells with an IC 50 of 10–25 nM. This compound also inhibited LPS-induced TNFα production in whole blood experiments (IC 50 100–1000 nM) and lowered serum levels of TNFα in mice when administered prior to LPS. 5Z-7- oxo-zeaenol was shown to inhibit the phosphorylation and activation of mitogen-activated protein kinase (MAPK) induced by LPS. These data are consistent with a mechanism of action at or upstream of MAPK with resultant downstream effects. This series of naturally occurring analogues represents an interesting group of compounds with diverse biological properties. Of this series, 5Z-7- oxo-zeanenol has exceptionally potent anti-inflammatory properties exhibited by its strong inhibition of cytokine production.</description><subject>5Z-7- oxo-zeaenol</subject><subject>5Z-7-^Aoxo-zeaenol</subject><subject>Adult</subject><subject>Animals</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - pharmacology</subject><subject>Ascomycota - chemistry</subject><subject>Biological and medical sciences</subject><subject>Bones, joints and connective tissue. Antiinflammatory agents</subject><subject>Humans</subject><subject>Hydroxybenzoates - pharmacology</subject><subject>L Cells (Cell Line) - drug effects</subject><subject>Lactones - pharmacology</subject><subject>Lipopolysaccharide</subject><subject>lipopolysaccharides</subject><subject>Lipopolysaccharides - antagonists &amp; inhibitors</subject><subject>Lipopolysaccharides - pharmacology</subject><subject>Macrolides</subject><subject>Macrophages - drug effects</subject><subject>MAP Kinase Signaling System - drug effects</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Mitogen-activated protein kinase</subject><subject>Molecular Structure</subject><subject>Monocytes</subject><subject>Pharmacology. Drug treatments</subject><subject>Receptors, Estrogen - metabolism</subject><subject>Receptors, Glucocorticoid - metabolism</subject><subject>Recombinant Fusion Proteins - pharmacology</subject><subject>Resorcylic acid lactones</subject><subject>Signal transduction</subject><subject>Structure-Activity Relationship</subject><subject>Tetradecanoylphorbol Acetate - pharmacology</subject><subject>tumor necrosis factor-^a</subject><subject>Tumor Necrosis Factor-alpha - biosynthesis</subject><subject>Tumour necrosis factor-alpha</subject><subject>U937 Cells - drug effects</subject><subject>Zearalenone - analogs &amp; derivatives</subject><subject>Zearalenone - chemistry</subject><subject>Zearalenone - isolation &amp; purification</subject><subject>Zearalenone - pharmacology</subject><issn>0192-0561</issn><issn>1879-3495</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><recordid>eNqFkbtuFDEUQC1ERJbAJ4BcIASFwZ7xY1xFKCIQKQoFoaGxPPadrNGsvdgzKEvDN_Ej-Sa8DwU65OLK0rmvcxF6xugbRpl8-5ky3RAqJHul9WtKKVeke4AWrFOatFyLh2hxjxyjx6V8q5BgsnmEjhmV9VG2QL8u4jL0YQop4jRgiD5N6TZEEqKfHXh8fXVO7n7jdU71v8NCxCvrclov7Q0U3G-w-EoUwek2kZ9gIaYR2-hxmpaQ8TDHGzviDCVltxmDw9YFj0frphShPEFHgx0LPD3EE_Tl_P312Udy-enDxdm7S-J4wyYCrNFCKSaZlVLZhjMOllupHai-dcL31DUMfCN813WyHVTrB9oJ1uqeNlK2J-jlvm5d5PsMZTKrUByMo42Q5mKY4i0XfAuKPVg3LCXDYNY5rGzeGEbN1rzZmTdbrUZrszNvupr3_NBg7lfg_8naq67AiwNgi7PjkG10ofzl6uFEt-1_useg2vgRIJviAsR6ipDBTcan8J9J_gDPAqCE</recordid><startdate>19991201</startdate><enddate>19991201</enddate><creator>Rawlins, Philip</creator><creator>Mander, Thomas</creator><creator>Sadeghi, Roya</creator><creator>Hill, Simon</creator><creator>Gammon, Guy</creator><creator>Foxwell, Brian</creator><creator>Wrigley, Stephen</creator><creator>Moore, Michael</creator><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>19991201</creationdate><title>Inhibition of endotoxin-induced TNF-α production in macrophages by 5Z-7- oxo-zeaenol and other fungal resorcylic acid lactones</title><author>Rawlins, Philip ; Mander, Thomas ; Sadeghi, Roya ; Hill, Simon ; Gammon, Guy ; Foxwell, Brian ; Wrigley, Stephen ; Moore, Michael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c421t-e129577161a667a2414ea4a69ce7b3c5db0c21ed25d88863f73df085139b02663</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>5Z-7- oxo-zeaenol</topic><topic>5Z-7-^Aoxo-zeaenol</topic><topic>Adult</topic><topic>Animals</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - pharmacology</topic><topic>Ascomycota - chemistry</topic><topic>Biological and medical sciences</topic><topic>Bones, joints and connective tissue. Antiinflammatory agents</topic><topic>Humans</topic><topic>Hydroxybenzoates - pharmacology</topic><topic>L Cells (Cell Line) - drug effects</topic><topic>Lactones - pharmacology</topic><topic>Lipopolysaccharide</topic><topic>lipopolysaccharides</topic><topic>Lipopolysaccharides - antagonists &amp; inhibitors</topic><topic>Lipopolysaccharides - pharmacology</topic><topic>Macrolides</topic><topic>Macrophages - drug effects</topic><topic>MAP Kinase Signaling System - drug effects</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Mitogen-activated protein kinase</topic><topic>Molecular Structure</topic><topic>Monocytes</topic><topic>Pharmacology. Drug treatments</topic><topic>Receptors, Estrogen - metabolism</topic><topic>Receptors, Glucocorticoid - metabolism</topic><topic>Recombinant Fusion Proteins - pharmacology</topic><topic>Resorcylic acid lactones</topic><topic>Signal transduction</topic><topic>Structure-Activity Relationship</topic><topic>Tetradecanoylphorbol Acetate - pharmacology</topic><topic>tumor necrosis factor-^a</topic><topic>Tumor Necrosis Factor-alpha - biosynthesis</topic><topic>Tumour necrosis factor-alpha</topic><topic>U937 Cells - drug effects</topic><topic>Zearalenone - analogs &amp; derivatives</topic><topic>Zearalenone - chemistry</topic><topic>Zearalenone - isolation &amp; purification</topic><topic>Zearalenone - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rawlins, Philip</creatorcontrib><creatorcontrib>Mander, Thomas</creatorcontrib><creatorcontrib>Sadeghi, Roya</creatorcontrib><creatorcontrib>Hill, Simon</creatorcontrib><creatorcontrib>Gammon, Guy</creatorcontrib><creatorcontrib>Foxwell, Brian</creatorcontrib><creatorcontrib>Wrigley, Stephen</creatorcontrib><creatorcontrib>Moore, Michael</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>International journal of immunopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rawlins, Philip</au><au>Mander, Thomas</au><au>Sadeghi, Roya</au><au>Hill, Simon</au><au>Gammon, Guy</au><au>Foxwell, Brian</au><au>Wrigley, Stephen</au><au>Moore, Michael</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inhibition of endotoxin-induced TNF-α production in macrophages by 5Z-7- oxo-zeaenol and other fungal resorcylic acid lactones</atitle><jtitle>International journal of immunopharmacology</jtitle><addtitle>Int J Immunopharmacol</addtitle><date>1999-12-01</date><risdate>1999</risdate><volume>21</volume><issue>12</issue><spage>799</spage><epage>814</epage><pages>799-814</pages><issn>0192-0561</issn><eissn>1879-3495</eissn><coden>IJIMDS</coden><abstract>Resorcylic acid lactones are fungal metabolites that exhibit a wide range of biological properties which includes oestrogenic, antifungal, phytotoxic and anti-inflammatory activity. The capacity of 5Z-7- oxo-zeaenol, a resorcylic lactone of fungal origin and six naturally occurring analogues to inhibit lipopolysaccharide (LPS)-induced cytokine production in phorbol 12-myristate-13-acetate (PMA)-treated cultured myelomonocytic cells (U937) was compared. The activity of the natural analogues in the U937 assay varied over 10 4-fold, with 5Z-7- oxo-zeaenol the most potent of those tested inhibiting tumour necrosis factor-alpha (TNFα) production in these cells with IC 50 of 6 nM. The isomeric 7- oxo-zeaenol and structurally more distant monorden (radicicol) were the next most active compounds with IC 50 ∼500 nM, and zearalenone, the least active with IC 50&gt;400 μM. 5Z-7- oxo-zeaenol retained activity in LPS-stimulated peripheral blood mononuclear cells with an IC 50 of 10–25 nM. This compound also inhibited LPS-induced TNFα production in whole blood experiments (IC 50 100–1000 nM) and lowered serum levels of TNFα in mice when administered prior to LPS. 5Z-7- oxo-zeaenol was shown to inhibit the phosphorylation and activation of mitogen-activated protein kinase (MAPK) induced by LPS. These data are consistent with a mechanism of action at or upstream of MAPK with resultant downstream effects. This series of naturally occurring analogues represents an interesting group of compounds with diverse biological properties. Of this series, 5Z-7- oxo-zeanenol has exceptionally potent anti-inflammatory properties exhibited by its strong inhibition of cytokine production.</abstract><cop>Oxford</cop><pub>Elsevier Science</pub><pmid>10606001</pmid><doi>10.1016/S0192-0561(99)00047-8</doi><tpages>16</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0192-0561
ispartof International journal of immunopharmacology, 1999-12, Vol.21 (12), p.799-814
issn 0192-0561
1879-3495
language eng
recordid cdi_proquest_miscellaneous_17434546
source ScienceDirect Freedom Collection
subjects 5Z-7- oxo-zeaenol
5Z-7-^Aoxo-zeaenol
Adult
Animals
Anti-Inflammatory Agents, Non-Steroidal - pharmacology
Ascomycota - chemistry
Biological and medical sciences
Bones, joints and connective tissue. Antiinflammatory agents
Humans
Hydroxybenzoates - pharmacology
L Cells (Cell Line) - drug effects
Lactones - pharmacology
Lipopolysaccharide
lipopolysaccharides
Lipopolysaccharides - antagonists & inhibitors
Lipopolysaccharides - pharmacology
Macrolides
Macrophages - drug effects
MAP Kinase Signaling System - drug effects
Medical sciences
Mice
Mice, Inbred BALB C
Mitogen-activated protein kinase
Molecular Structure
Monocytes
Pharmacology. Drug treatments
Receptors, Estrogen - metabolism
Receptors, Glucocorticoid - metabolism
Recombinant Fusion Proteins - pharmacology
Resorcylic acid lactones
Signal transduction
Structure-Activity Relationship
Tetradecanoylphorbol Acetate - pharmacology
tumor necrosis factor-^a
Tumor Necrosis Factor-alpha - biosynthesis
Tumour necrosis factor-alpha
U937 Cells - drug effects
Zearalenone - analogs & derivatives
Zearalenone - chemistry
Zearalenone - isolation & purification
Zearalenone - pharmacology
title Inhibition of endotoxin-induced TNF-α production in macrophages by 5Z-7- oxo-zeaenol and other fungal resorcylic acid lactones
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T06%3A10%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inhibition%20of%20endotoxin-induced%20TNF-%CE%B1%20production%20in%20macrophages%20by%205Z-7-%20oxo-zeaenol%20and%20other%20fungal%20resorcylic%20acid%20lactones&rft.jtitle=International%20journal%20of%20immunopharmacology&rft.au=Rawlins,%20Philip&rft.date=1999-12-01&rft.volume=21&rft.issue=12&rft.spage=799&rft.epage=814&rft.pages=799-814&rft.issn=0192-0561&rft.eissn=1879-3495&rft.coden=IJIMDS&rft_id=info:doi/10.1016/S0192-0561(99)00047-8&rft_dat=%3Cproquest_cross%3E17434546%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c421t-e129577161a667a2414ea4a69ce7b3c5db0c21ed25d88863f73df085139b02663%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17434546&rft_id=info:pmid/10606001&rfr_iscdi=true